The role of the MolecuLight i:X in potential improvement of current debridement practices

December 7, 2017 -Are standard debridement practices maximizing removal of bioburden?

The current gold standard for tissue management in diabetic foot ulcers is regular sharp debridement to reduce bioburden. However, a recent study by Rose Raizman, RN-EC MSc, a wound care clinician, which used bacterial fluorescence imaging with the MolecuLight i:X after initial, aggressive debridement

Predicting the presence of pathogenic bacteria in wounds

August 30, 2017 -Why wouldn’t you want to be 100% certain about bacterial presence?

In the recent publication in the Journal of Wound Care ‘Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study’1,… Read More

Fish skin for human wounds: Iceland’s pioneering treatment

August 2, 2017 -The FDA-approved skin substitute reduces inflammation and transforms chronic wounds into injuries.

Kerecis Ltd, a small company in Iceland has the only FDA-approved skin substitute derived from fish.

Fertram Sigurjonsson is the Chairman and CEO of Kerecis.  His small company has spent the past nine years applying fish skin to

Antibiotic resistance continues to be a real issue

January 16, 2017 -Case of Nevada women another sign that antibiotic resistance must be taken seriously

Public health officials from Nevada are reporting on a case of a woman who died in Reno in September from an incurable infection caused by Klebsiella pneumoniae bacteria. Testing showed the superbug that had spread throughout her

MolecuLight Inc. participates as a secret Santa in the Adopt-a-Senior program

December 23, 2016 -

Keeping up with their tradition, MolecuLight Inc. participated as a secret Santa in the Adopt-a-Senior 2016 program through LOFT Community Services. This charity provides attention to seniors who deal with loneliness and uncertainty at this special time of the year.

MolecuLight Inc. would like to wish everyone a happy and healthy

The latest innovations in wound diagnostics

August 23, 2016 -Reviewing medical imaging in wound care

There’s no doubt that while medical imaging is standard and routine in most medical fields (e.g. cardiology, oncology, gynecology, etc.), it is far behind in the field of wound care. The recent editorial in Advances in Wound Care highlights the key points of four

MolecuLight gives back during the holiday season

December 22, 2015 -MolecuLight participated in the Adopt-a-Senior 2015 program

This holiday season, MolecuLight participated in the Adopt-a-Senior 2015 program through LOFT Community Services. This charity provides attention to seniors who deal with loneliness and uncertainty at this special time of the year.

MolecuLight would like to wish everyone a happy and health

Evaluation of surgical site infections with fluorescence imaging

June 25, 2015 -Enabled better detection of otherwise subclinical bacterial colonization in surgical sites

At MHSRS (Military Health Science Research Symposium, 2014) a study was presented examining the effectiveness of the MolecuLight i:X for detecting subclinical bacterial contamination and guiding antimicrobial wound treatments. Handheld fluorescence imaging, used adjunctively with standard clinical signs and